home page

Board of Directors

Andrew Sandham, (Chairman)
Lawrence Bloch, MD, JD
Aaron Davidson
Kenneth Galbraith
Jonathan R. Goodman
Richard Meadows
Deepa Pakianathan, PhD
Samuel P. Wertheimer, PhD

Leadership

Management Team
Board of Directors
Board Observers
Scientific Advisory Board



Richard Meadows, Managing Director, CTI Life Sciences Fund

Richard has made and managed numerous investments in biotechnology therapeutic development companies and has represented investors on over a dozen boards of directors. Prior to joining CTI, Mr. Meadows was a Venture Partner with VantagePoint Venture Partners, a $2.5BUS private equity fund based in San Bruno, California. Prior to his employment with VantagePoint, Mr. Meadows was a Partner in the Biotechnology Group of CDP Capital Technology Ventures, a $1B Fund.

Home | NeurAxon | Market | Pipeline | Research | News | Contact